Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05542056

Urinary Prostaglandin as a Potential Predictive Marker for Thiazide-induced Hyponatremia

Sponsor: University Hospital, Basel, Switzerland

View on ClinicalTrials.gov

Summary

Thiazides and thiazide-like diuretics are one of the five major classes of antihypertensive drugs. This study is to investigate whether urinary PGE2 concentration at baseline (prior to thiazide initiation) is associated with the development of TIH within the first four weeks of treatment.

Official title: Urinary Prostaglandin as a Potential Predictive Marker for Thiazide-induced Hyponatremia: a Prospective Cohort Study (The PROPHECY Study)

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

232

Start Date

2022-09-26

Completion Date

2026-07

Last Updated

2025-07-01

Healthy Volunteers

No

Interventions

OTHER

Data and biosample collection

Collection of spot urine, blood sampling, vital parameters, body weight, medical history, patient questionnaires, drinking protocol, drug diary at at Visit 1 (before thiazide initiation), at Optional 2 hours-challenge, at Visit 2 (4 weeks after thiazide initiation), at Visit 2.1 (4 weeks after dose change), at Visit 3 (3-months after thiazide initiation)

Locations (3)

Hospital Universitario de Móstoles

Móstoles, Spain

University Hospital Basel, Endocrinology, Diabetes and Metabolism

Basel, Switzerland

Kantonsspital Baselland

Liestal, Switzerland